Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial
Entospletinib联合地西他滨治疗TP53突变或复杂核型急性髓系白血病:Beat AML Master试验的II期子研究
期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.34780
Duong, Vu H; Ruppert, Amy S; Mims, Alice S; Borate, Uma; Stein, Eytan M; Baer, Maria R; Stock, Wendy; Kovacsovics, Tibor; Blum, William; Arellano, Martha L; Schiller, Gary J; Olin, Rebecca L; Foran, James M; Litzow, Mark R; Lin, Tara L; Patel, Prapti A; Foster, Matthew C; Redner, Robert L; Al-Mansour, Zeina; Cogle, Christopher R; Swords, Ronan T; Collins, Robert H; Vergilio, Jo-Anne; Heerema, Nyla A; Rosenberg, Leonard; Yocum, Ashley O; Marcus, Sonja; Chen, Timothy; Druggan, Franchesca; Stefanos, Mona; Gana, Theophilus J; Shoben, Abigail B; Druker, Brian J; Burd, Amy; Byrd, John C; Levine, Ross L; Boyiadzis, Michael M